So proud of my friends and colleagues Trisha Santos, MD, MS and Chris Jackson, MD MS for their Conquer Cancer, the ASCO Foundation ASCO awards 🥳🤩🚀

📜 With Drs @KenrickNg1 @J_Shamash Paul Nguyen, we respond to work by Prof Potosky et al, shedding light on global #QoL among #patients w #prostate #cancer

🙏 JCO Oncology Practice for the invitation to write

🔗 ascopubs.org/doi/10.1200/OP…

Important work from Priyamvada Maitre Vedang Murthy and team 🚀

👏 SO proud of Tej A. Patel who is a 2024 #Truman #Scholar from MA.

🤩 It is a #privilege to be a colleague of this future leader and shaker in #medicine , #health policy, and (hopefully!) #oncology

Penn Truman Scholarship

🔗 penntoday.upenn.edu/news/two-penn-…

ENZA-P in The Lancet Oncology

Lu-177 PSMA-617 + enzalutamide vs. enza alone:

● ↑PFS: 13.0 vs 7.8, hazard radio 0.43
● PSA90 response 78% vs 37%
● PSA50 response 93% vs. 68%
● no additional side effects

Incredible work from Louise Emmett Ian Davis & ANZUP team

Woooo go Kaitlyn Lapen Erin Gillespie, MD MPH and team!! 🤩🤩🤩 Memorial Sloan Kettering Radiation Oncology

Prostate cancer cases are projected to double to 2.9 million per year by 2040.

🆕 A Lancet Commission outlines evidence-based interventions, such as improved early detection & education programmes, to help save lives & prevent related ill health. hubs.li/Q02snzFs0

Agnostic ADCs are finally here. Huge opportunity for thousands of patients, but plenty of challenges! We need better biomarkers, an improved understanding of ADC sequencing and strategies to decrease toxicities. acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca… Roberto Pestana, MD G Curigliano MD PhD Chiara Corti Sara Tolaney

A surge is coming.....
Honoured to be part of this huge effort pulled off by a team led by Nick James
A 20 year view of what #prostatecancer will do and what we can do about it as caregivers and policy makers in HIC and LMIC.
The Lancet Commission out today at #EAU24

A must read paper in CA: A Cancer Journal for Clinicians and American Cancer Society on the GLOBAL burden of cancer: insights into trends, interventions and priorities worldwide!

OncoAlert Karen Knudsen, MBA PhD

acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca…

Sunday symmetree 🌳☀️

🧠 honored to be on this journey at Memorial Sloan Kettering Radiation Oncology with colleagues who’ve become dear friends Roshal Patel Alex Goglia Jeff Meng Nikhil Mankuzhy, MD Kaitlyn Lapen 🚀🍄🥳

🤩 immensely proud of my friend Dr Miguel de Jesus, fellow #Filipino in #science at ⁦Memorial Sloan Kettering Cancer Center⁩, who defended his thesis this week

🚀 a true philosopher, scientist, and #karaoke master, proud of you ⁦Miguel DJ⁩

🥳 gorgeous slides that flew over my 🧠

🤩🤩🤩 Erin Feliciano Kaisin Yee Frances Ho Joseph Paguio, MD Michelle Ann B. Eala, MD 🇵🇭 Tricia Robredo Kenrick Ng The Lancet Reg Health-West Pacific

Cancer is anarchy in cellular form. As a cancer survivor and now cancer doctor, I am keenly aware that cancer is a devious enemy. Cancer cells flout the rules of a normal cellular society but most often remain under the radar. 1/3

Ha Jin:

🙏 Honored to be interviewed by The Lancet Oncology on #cancer control in #SoutheastAsia and the #Philippines 🇵🇭

📜 Improved #screening access must be matched by improved access to #affordable and sustainable #treatment 🌏

🔗 thelancet.com/journals/lanon…

📖' #Artificial #Intelligence for #Medicine ' will be available from 03/27. Useful for academics, professionals in IT industry, educators, students, & anyone involved in AI in the medical field. G Curigliano MD PhD Carmen Criscitiello MIT Critical Data Elsevier
🔜shorturl.at/ckoMQ

“…and somewhere, each of us must help the other die.”

⁦Adrienne Rich Bot⁩

“From Line” by Lee Ufan